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Abstract:
Background: Medication adherence is a dynamic and complex behavioral process, which is strongly influenced by personal, 
social and environmental factors.
Objectives: To determine the prevalence and factors affecting non-adherence to medication among HIV-infected patients.
Methods and materials:
Design: A cross-sectional study.
Setting: Voluntary Counseling and Testing Center (VCT), Shiraz, Fars province, in the South of  Iran.
Patients: Among HIV-positive patients who received anti-retroviral therapy, 214 adult patients were selected through conve-
nience sampling. Their medication adherence was checked by interview and counting the pills on visits during two months. 
Clinical and laboratory data were obtained from the patients' records.
Results: Non-adherence and adherence groups included 30.4% (65) and 69.6% (149) of  the patients, respectively. The mean age 
of  patients was 40.80±7.77 years, and ranged from 20 to 65 years. Majority of  cases (65%) were male. A significant relationship 
was found between non-adherence to medications and the variables of  transmission method, marital status, housing status, and 
CD4, but there was no significant relationship with gender.
Conclusion: The prevalence of  medication adherence was similar to other regions with limited financial resources. To increase 
patient’s medication adherence, they should be exposed to motivational interventions to promote their drug consumption, social 
and occupational support.
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Introduction
Background: Anti-retroviral medication suppresses viral 
replication in HIV-infected individuals. Evidence shows 
that broader and earlier commencement of  ART can re-
duce HIV rate1. High level drug adherence for a long pe-
riod of  time is necessary to suppress viruses2. Medication 
adherence is a dynamic and complex behavioral process, 
strongly influenced by the personal, social and environ-
mental circumstances3.
Medication non-compliance was reported as 45% in the 
USA4. Other studies in Africa and Asia have shown that 
more than 70% of  HIV-positive young adults and ado-
lescents receiving anti-retroviral medication were adher-
ent to their prescription, but adherence rate was lower in 
Europe and North America (50-60%). These differences, 
which are multifactorial, represent the difference between 
centralized and distributed epidemic as well as access to 
health systems and resources5.
Corresponding author: 
Nasrin Motazedian, 
Shiraz Transplant Research Center, 
Shiraz University of  Medical Sciences, Shiraz, Iran,
 Seventh floor, Transplant Research Center, 
Mollasadra St., Khalili Ave., Mohammad Rasulallah, 
Research Tower, Shiraz, IR Iran.




© 2018 Motazedian et al. Licensee African Health Sciences. This is an Open Access article distributed under the terms of  the Creative commons 
Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.   
African Health Sciences Vol 18 Issue 2, June, 2018384
There are significant obstacles to medication adherence 
amongst HIV-infected individuals and occurrences such 
as food shortages, financial constraints, forgetfulness, fear 
of  being labeled, and stigma as well as the psychosocial 
aspects of  the illness (e.g.anxiety and depression) directly 
or indirectly affect their behavior.
Higher trust or satisfaction rate with the HIV caregiv-
er, lower daily dose frequency and not having depression 
symptoms were strongly linked to higher adherence in 
low and medium Human Development Index countries 
than in high Human Development Index countries6,7,8.
Among the established indices, high social status (income, 
education, employment status) was associated with higher 
adherence to anti-retroviral drugs9. Adherence may also 
vary according to gender10.
Among the psychosocial factors, certain aspects of  the 
relationship between patient and care providers, such as 
the service provider’s ability and skills, trust, open com-
munication, willingness to consume their medication, and 
general satisfaction were significantly related to higher 
rates of  adherence11.
Another study showed non-adherence key factors: being 
away from home, being busy and forgetfulness12. Howev-
er, systematic review of  the available evidence does not 
provide conclusive evidence of  a clear relationship be-
tween socio-economic status and adherence to anti-HIV 
drugs in young adults infected with HIV/AIDS in low 
and middle income countries. It seems that a positive re-
lationship exists between the components of  socio-eco-
nomic status (income, education, and employment) and 
adherence to anti-retroviral medication13.
However, compelling a patient to take medicine for the 
rest of  his/her life without forgetting a dose is challeng-
ing.  Medication adherence factors might vary from one 
patient to another and from time to time. 
Objectives: The present study aimed to determine the 
prevalence and factors affecting medication adherence 
among HIV-infected patients referred to Voluntary 
Counseling and Testing (VCT) center of  Shiraz, Iran.
Methods and materials
Study design: This was an analytical cross-sectional 
study.
Study setting:  Our study was conducted in Shiraz VCT 
center. Shiraz VCT center is the only center in Fars prov-
ince (in the South of  Iran) that provides pharmaceuti-
cal and healthcare consultation services to these patients. 
Hence, all identified HIV/AIDS individuals in Fars 
province attend this center. We collected data during two 
months of  March-April 2014. Patients’ medication ad-
herence was checked through interview and counting of  
the pills during their visits in each month. This study was 
approved by the local Ethics Committee of  the Shiraz 
University of  Medical Sciences.
Study size: The minimum sample size was calculated ac-
cording to our objectives, and the non-adherence preva-
lence of  30% from a previous study with 95% confidence 
interval, error estimation of  5%. The formula   
                       
                       























Participants: Among HIV-infected patients referred to 
Voluntary Counseling and Testing (VCT), center of  Shi-
raz, Iran, 224 adult patients were selected through con-
venience sampling. Finally, 214 patients with complete 
medical records and good cooperation were enrolled in 
this study. Convenience sampling was used, since most of  
those who participated were drug addicts and they were 
not willing to participate in our study. In order to have 
comprehensive coverage of  all the patients, samples were 
collected every day during opening hours of  the center 
(Figure 1).
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Figure 1. Flow chart for selection of study participants 
The study objectives were explained and participants 
were assured that their information will remain confiden-
tial. Those who had the inclusion criteria and were willing 
to participate in the study signed a written informed con-
sent and were enrolled in the study. All adolescents were 
excluded, and the next person who met the inclusion cri-
teria was recruited.
Variables: The form for data collection included socio-
demographic questions such as age, gender, and marital 
status, type of  accommodation, place of  residence, level 
of  education, income level, and employment. Factors re-
lated to compliance included: assistant in drug consump-
tion, access to daily meals, methadone consumption, and 
travelling time to the center. Mode of  HIV transmission, 
hospitalization, CD4, BMI, and clinical staging, were ob-
tained from the patient's medical records.
Adult patients were selected through convenience sampling during March-April 2014
m=224 
AIDS patients who referred to VCT to receive antiretroviral 
therapy
N=730 
  Patients were excluded if they were unwilling to participate or had incomplete 
medical records. 
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Bias: Our study was a cross sectional study and was sus-
ceptible to the effects of  selection bias and recall bias. 
The potential for selection bias was minimized by extend-
ing the study time daily during the opening hours of  the 
center. To minimize recall bias, we excluded patients who 
could not correctly remember their medical consumption 
and/or their medical records were incomplete.
Statistical methods: Quantitative data was reported 
using Mean ± SD and qualitative data was expressed as 
percentages. Missing data was ignored and complete data 
was analyzed using chi-square and t- test. Also, we used 
logistic regression model to control the confounders us-
ing SPSS-18. The significance level was considered at 5% 
for all tests.
Results
Participants: This study was designed to investigate fac-
tors influencing non-compliance to medication in patients 
with HIV/AIDS in Shiraz, Iran. A total of  214 patients 
were divided into two groups according to medication ad-
herence or non-adherence, and were compared.
Based on the results, 30.4% (65) of  patients were non-ad-
herent and 69.6% (149) showed good adherence to their 
medication protocols. The most important reason for 
discontinuation of  medication was the patients’ unknown 
personal reasons (n=60, 61.2%), from the non-adherence 
group. In 168 participants (78.5%), Zidovudine (AZT), 
Lamivudine (3TC), and Efavirenz (EFV) were the first 
drug of  choice.
Descriptive data: The patient's age range was 20-65 
years with an average of  40.80±7.77 years. The major-
ity of  cases (65%) were male. Variables of  age, gender, 
employment, housing, marital status, and education level 
in both groups are summarized in Table 1. Most of  the 
subjects (53.3%) were married, and 32.7% had a middle 
school degree.
Outcome data: According to Table 1, the variables of  
gender, marital status, housing, and occupation had a sig-
nificant association with non-adherence to medication. 
This was more common amongst men and in unmar-
ried (single, divorced, or widowed) than married couples. 
Those with unsteady occupations   adhered better to their 
medication than the unemployed participants.
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Time of  access to VCT center for people in the non-ad-
herence and adherence groups was 54.38 ± 58.9 and 69.26 
± 78.26 minutes, respectively (p=0.110 and t=1.608), but 
the difference was not statistically significant.
History of  hepatitis C and hospitalization was reported 
in 30.5% and 55.2% (116 patients), respectively. Non-ad-
herence patients with history of  hospitalization were 
more than those without hospitalization history (35.3% 
vs. 22.3%), and this difference was statistically significant 
(p=0.040, X2=4.22). (Table 2)
Length of  hospital stay was different among participants 
(ranging from 1 to 180 days with an average of  20.95 ± 
37.36 days). They were admitted for various reasons, with 
surgery being the most common (24.5%).
The majority of  patients in both groups (n=132, 62.3%) 
stated that no one assisted them in drug consumption, 
Table 1: Evaluation and comparison of demographic and socio-economic characteristic in 




index p-value Non-adherence Adherence 
Age (Mean ± SD) 41.68±6.6 40.42±8.22 1.09 0.276 
Gender 
(%) 




(n=99) 43 (67.2) 56 (37.6) 15.7 <0.001* 
Married (n=114) 21 (32.8) 93 (62.4) 
Education 
(%) 
Illiterate (n=9) 1 (1.5) 8 (5.4) 
4.5 0.21 
Primary school (n=69) 26 (40) 43 (28.9) 
Middle school (n=70) 22 (33.8) 48 (32.2) 
High school and higher 
(n=66) 16 (24.6) 50 (33.6) 
Location 
(%) 
City (n=190) 61 (32.1) 129 (67.9) 2.4 0.121 Village (n=24) 4 (16.7) 20 (83.3) 
Housing 
(%) 
Personal house (property) 
(n=39) 5 (7.7) 34 (22.8) 
17.8F <0.001* 
Personal house (leased) 
(n=93) 22 (33.8) 71 (47.7) 
Living with a family 
(n=79) 37 (56.9) 42 (28.2) 
Other (n=3) 1 (1.5) 2 (1.3) 
Occupation 
(%) 
Steady (44) 10 (15.4) 33 (22.8) 
6.16 0.046* Non-steady (n=34) 6 (9.2) 28 (19.3) 
Unemployed (n=133) 49 (75.4) 84 (57.9) 
Income 
status (%) 
Less than 3000000 Iranian 
Rials(100 USD†) (n=23) 4 (17.4) 19 (82.6) 
0.393 0.942 
3000000 to 5000000 
Iranian Rials(100-166 
USD) (n=24) 
4 (16.7) 20 (83.3) 
5000000 to 10 million 
Iranian Rials(166-332 
USD (n=27) 
6 (22.2) 21 (77.8) 
10 to 15 million Iranian 
Rials (332-497 USD) 
(n=4) 
1 (25) 3 (75) 
   * Statistically significant 
   † United States Dollar (USD)  
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which had no significant association with non-adherence 
to medication. In addition, 202 patients (94%) stated that 
medical staff  had explained drug consumption methods 
and their possible side effects.
Non-adherence was lower in those who took methadone 
(58%) than those who did not use it (18.7%), which had a 
significant association with non-adherence to medication 
(p=<0.001, X2=32.34) (Table 2).
CD4 ranged from 11 to 688 with a mean of  179.9 ± 
115.8, with a significant difference in the two groups. 
BMI of  the participants varied from 12.4 to 37.7 with a 
mean of  23.2 ± 4.38, but was not significant.
In the studied patients, 40.4%, 39.9%, 17.4%, and 2.3% 
were in clinical stages of  1, 2, 3, and 4, respectively, which 
had no significant difference in terms of  adherence and 
non-adherence to medication. (Table 2)
Table 2: Comparing factors associated with adherence to anti-retroviral 
therapy, in Fars province, 2014 
Variables 
Group Statistical 
index p-value Non-adherence Adherence 
Travelling time to the center 54.38 ± 58.9 70.5 (83.26) T=1.608 0.110* 
Mode of HIV 
transmission 
Drug injection 
(n=43) 24(38.1) 19 (12.9) 
X2 = 23.8 <0.001* 
Sexual contact 
(n=18) 3 (4.8) 15 (10.2) 
Drug injection and 
sexual contact 
(n=82) 
26 (41.3) 56 (38.1) 
Spouse of the 
patient (n=52) 6 (9.5) 46 (31.3) 
Other (n=15) 4 (6.3) 11 (7.5) 




Family (n=66) 26 (39.4) 40 (60.6) 
X2=5.2 0.074 Patient (n=132) 35 (26.5) 97 (73.5) Family and patient 
(n=14) 2 (14.3) 12 (85.7) 
Access to 
regular food 
Yes (n=168) 53 (81.5) 115 (78.2) X2 = 0.3 0.584 No (n=44) 12 (18.5) 32 (21.8) 
Methadone 
consumption 
Yes (n=69) 40 (61.5) 29 (21) X2=32.34 <0.001* No (n=134) 25 (38.5) 109 (79) 
CD4 163.74±226.77 202.1±326.55 t=3.5 <0.001* 
BMI 22.26±4.9 23.32±4.1 T=1.57 0.116 
Clinical staging 
1(n=86) 21 (32.3) 65 (43.9) 
X2=5.49 0.139 2(n=85) 54 (36.5) 31 (47.7) 3(n=37) 24 (16.2) 13 (20) 
4(n=5) 0 (0) 5 (3.4) 
Social support score 29.3±4.6 28.40±3.58 X2=1.51 0.132 
* Statistically significant 
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The social support score ranged from 23 to 51 with a 
mean of  28.67 ± 3.94, but that was not significant.
Main results: To evaluate adherence to medication, the 
multiple logistic regression analysis was used and a signif-
icant relationship was found between the non-adherence 
group and the variables of  transmission method, marital 
status, housing, and CD4. However, the data in this study 
did not show any significant relationship with gender. 
Among the significant variables, transmission method 
and marital status had a reverse relationship with non-ad-
herence (Table 3).
Discussion
Key results: In this study, the prevalence of  adherence 
was evaluated and the factors involved in both groups 
were compared. The rate of  non-adherence in the pres-
ent study was 30.4%.
Multiple logistic regression analysis showed a significant 
relationship between non-adherence to medication and 
the variables of  transmission method, marital status, 
housing, and CD4, however, the data did not show a sig-
nificant association with gender.
Interpretation: According to literature, medication ad-
herence is higher in countries with limited financial re-
sources than the advanced countries5,14,15,16. Studies from 
countries with strong financial resources have shown that 
less than 50% of  patients take all anti-retroviral drugs on 
time as directed by caregivers14. Nonetheless, these results 
were lower than the results of  our study. The majority of  
the participants in our study stated that medical staff  had 
explained how to consume drugs, the advantages, and the 
side effects of  the medications before initiation of  the 
therapy, which could be the reason for their adherence 
to medication. In addition, VCT center in Shiraz supplies 
free HAART (highly active anti-retroviral therapy), physi-
cian visit, and CD4 count test for all HIV/AIDS patients.
Adherence rate is related to resources and availability of  
healthcare facilities. For example, HIV screening and pro-
viding ART (anti-retroviral therapy) are widespread, with 
door to door testing and care in underprivileged regions. 
It is also free of  charge for disadvantaged people5. This 
could also be a good reason for the higher adherence rate 
in these regions.
 
Table 3: The socio-demographic, behavioral, and clinical predictors of  
non-adherence to antiretroviral therapy, in Fars province, 2014 
 
Variables Adjusted OR p-value  (95% CI) 
Mode of HIV transmission       
Drug injection Ref     
Sexual contact 0.068 0.005 0.010-0.445 
Drug injection and sexual 
contact 0.297 0.011 0.117-0.755 
Spouse of the patient 0.505 0.509 0. 066-3.836 
Other 0.637 0.594 0.122-3.335 
Marital status       
Single/divorced/widowed Ref     
Married 0.181 <0.001 0.073-0.444 
Housing       
Personal (property) Ref     
Personal (leased) 3.723 0.046 1.025-13.530 
Living with family 7.080 0.002 2.025-24.748 
Other 1.251 0.872 0.082-19.004 
Gender       
Female Ref     
Male 4.800 0.074 0.860-26.804 
CD4 0.996 0.001 0.994-0.998 
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In most of  the women who were infected through their 
husbands, the gender variable had a significant relation-
ship with medication adherence using Chi-square anal-
ysis. On the contrary, according to logistic regression 
analysis no significant relationship was found. Another 
study in Shiraz showed that even though women referred 
later to health care centers (mostly in the AIDS phase), 
but they visited more regularly and complied better with 
medication in comparison to men. However, survival 
rates did not differ between men and women17. Another 
study showed that men had less adherence in taking ART 
medication18. A study in India did not find a significant 
relationship between gender and drug adherence, which 
could be due to small sample size15. It could also be due to 
the different levels of  stigma and violence against women 
in different regions.
Consumption of  methadone was reported more in the 
non-adherence group, and drug abuse could be the rea-
son. Among the non-adherence group in the present 
study, 38.1% of  patients were intravenous drug users.
In logistic regression analysis it was shown that adherence 
to medication was higher in those infected through sexual 
contact or drug use in comparison to drug users group. It 
seems that these people were non-adherent to medication 
due to drug addiction.  A study showed non-adherence 
is more in people who use drugs19.  Another study that 
compared adherence to medication among intravenous 
drug users (IDUs) and non-intravenous drug users infect-
ed with HIV/AIDS showed that injecting drug users had 
a higher rate of  non-adherence20.
It is unclear as to why those with high CD4 count had 
higher adherence to medication. A study in the USA ob-
tained a higher mean CD4 in patients with medication 
adherence than those without medication adherence, and 
this difference was significant. This was consistent with 
the results of  the present study21. But the results of  a 
study in South India showed that people with CD4 of  
more than 500 cells per microliter and long-term drug 
users had less adherence to medication; this might be due 
to boredom of  taking a drug for a long period of  time22. 
One explanation is that people with higher CD4 felt bet-
ter and those who were health illiterate did not take their 
medication correctly.
Married individuals have a better chance of  medication 
adherence than single people.Living alone and being un-
employed were also factors involved in non-adherence 
to medication in our study. A study in Vietnam obtained 
similar results23. Another study showed that living alone 
led to lower adherence24. Being a couple can help people 
to remind each other to consume their medications and 
accompany each other to centers; hence, better adher-
ence.
A systematic review reported a significant relationship 
between the elements of  SES (education, income, and 
occupation) and adherence to medication9. The major-
ity of  the participants in our study did not answer the 
income question rendering it un-analyzable, but occupa-
tion had a significant relationship between groups, and 
the majority of  patients in the non-adherence group were 
unemployed. The housing situation also had a significant 
relationship with their adherence. Most people with ad-
herence to medication had private homes, but most peo-
ple in the non-adherence group were either living with 
family or had to pay rent. It seems that stable conditions 
including married life and having a home might be help-
ful in their adherence.
In the present study, no significant relationship existed 
between social support and medication adherence. In 
general, factors determining socio-economic status are 
related to cultural, economic, and geographic factors. For 
this reason, studies achieved different outcomes due to 
different contexts. Adherence to medication varies in dif-
ferent countries. It is suggested that geographical location 
should be considered.
The present study was the first research performed on 
people with HIV/AIDS in Shiraz, in which the preva-
lence of  medication adherence and its affecting factors 
were evaluated. This study can be a benchmark for other 
interventional and longitudinal studies.
Limitations
This is a cross sectional study, which was conducted in 
one center and might not be applicable for other regions.
Conclusion
The rate of  medication adherence in this study was similar 
to other regions with limited financial resources. There-
fore, to increase adherence, patients should be exposed 
to motivational interventions for drug consumption and 
social and occupational support. Medication and medical 
care should be widespread, provide more over the phone 
African Health Sciences Vol 18 Issue 2, June, 2018 391
and social workers services. Since medication adherence 
is a dynamic process and changes over time, it is suggest-
ed to design a longitudinal study to achieve better results 
and higher adherence to drug therapy through monitor-
ing medication and understanding the factors involved in 
non-adherence in bigger sample sizes over time.
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